期刊文献+

息肉状脉络膜血管病变的吲哚菁绿眼底血管造影分型研究 被引量:6

Angiographic classification of polypoidal lesions in polypoidal choroidal vasculopathy on indocyanine green angiography
原文传递
导出
摘要 目的 分析黄斑区息肉状脉络膜血管病变(PCV)在吲哚菁绿眼底血管造影(ICGA)中的不同渗漏亚型及临床特点.方法 对经荧光素眼底血管造影(FFA)及ICGA确诊为PCV的137例144只患眼进行ICGA渗漏状态的分型及各型临床特点的分析.结果 在144只PCV患眼的ICGA中,110只眼出现晚期染料渗漏(渗漏型,76%).渗漏型又可分为三个亚型:息肉灶渗漏型(47只眼,42.7%)、异常分支状脉络膜血管渗漏型(14只眼,12.7%)和混合渗漏型(49只眼,44.5%).其他34只眼显示出晚期病灶的消退和(或)呈冲刷现象(消退型,24%).在渗漏型中,色素上皮脱离(PED)、最佳矫正视力(BCVA)〈0.1及陈旧性视网膜下出血的比例分别为56.4%(62只眼),19.1%(21只眼)和4.6%(5只眼);消退型相应比例分别为8.8%(3只眼)、50%(17只眼)和38.2%(13只眼)(P〈0.001),同时消退型的病程显著长于渗漏型(P〈0.001).结论 在ICGA中可以观察PCV病灶的晚期渗漏及消退现象,其中以渗漏型居多.混合性渗漏是渗漏型中最常见的亚型.渗漏型多表现PED,较好的BCVA以及较短的病程,而消退型则更易表现视网膜下陈旧性出血、较差的BCVA以及较长的病程.这可能提示前者为活动性病灶或处于疾病的早期阶段,而后者则为静止性病灶或处于疾病的晚期阶段. Objective To investigate the angiographic classification of polypoidal lesions in polypoidal choroidal vasculopathy (PCV) on indocyanine green angiography (ICGA). Methods One hundred and forty four eyes of 137 patients diagnosed as PCV were prospectively observed. Fundus examination, color fundus photography and ICGA were performed. Angiographic classification of polypoidal lesions and clinical features were recorded. Results In all 144 eyes, 110 eyes showed angiographic leakage (leakage group, 76%) on ICGA and three subtypes of the leakage group were noted, which were polypoidal dilations leakage (47 eyes, 42.7%), branching vascular networks leakage (14 eyes, 12.7%) and leakage of both (49 eyes, 44.5%). The other 34 eyes showed regression of polypoidal lesions (regression group, 24%). In leakage group, the rates of pigment epithelial detachment (PED), best corrected visual acuity (BCVA) 〈0.1 and old subretinal hemorrhages were respectively 56.4% (62 eyes), 19.1% (21 eyes), and 4.6% (5 eyes), compared with 8.8% (3 eyes), 50% (17 eyes) and 38.2% (13 eyes) for regression group (P〈0.001). The history of regression group was significantly longer (P〈0.001). Conclusions Angiographic leakage and regression can be observed in PCV lesions. Leakage of both polypoidal dilations and branching vascular networks is the most common subtype in leakage group. PCV in leakage group is more likely to be related to PED, better BCVA and shorter history, while PCV in regression group tends to relevant to old subretinal hemorrhage, worse BCVA and longer history. This may reflect the former is active or in the early course while the latter is resting or in the late phase of PCV.
出处 《中国实用眼科杂志》 CSCD 北大核心 2010年第5期479-483,共5页 Chinese Journal of Practical Ophthalmology
基金 国家重点基础研究发展计划(973计划2007CB512206)
关键词 息肉状脉络膜血管病变 吲哚菁绿血管造影 荧光素眼底血管造影 Indocyanine green angiography Polypidal choroidal vasculopathy Fundus fluorescein angiography
  • 相关文献

参考文献15

  • 1Yannuzzi LA,Wong DW,Sforzolini BS,et al.Polypoidal choroidal vas-culopathy and neovascularized age-related macular degeneration[J].Arch Ophthalmol,1999,117(11):1503-1510.
  • 2Lafaut BA,Leys AM,Snyers B,et al.Polypoidal choroidal vasculopathy in Caucasians[J].Graefes Arch Clin Exp Ophthalmol,2000,238(9):752-759.
  • 3Sho K.Takahashi K.Yamada H,et al.Polypoidal choroidal vasculopathy:incidence,demographic features,and clinical characteristics[J].Arch Ophthalmol,2003,121(10):1392-1396.
  • 4Liu Y,Wen F,Huang S,et al.Subtype lesions of neovascular age-related macular degeneration in Chinese patients[J].Craefes Arch Clin Exp Ophthalmol,2007,245(10):1441-1445.
  • 5Michels S,Hansmann F,Geitzenauer W,et al,Influence of treatment parameters on selectivity of verteporfin therapy[J]..Invest Ophthalmol Vis Sci,2006,47(1):371-376.
  • 6Bozzoni Pantaleoni F,Magliari Galante V,Da Dalt S,et al.Looalizing polypoidal choroidal vasculopathy for laser treatment[J].Acta Ophthalmol Scand,2007,85(4):456-458.
  • 7Akaza E,Mori R,Yuzawa M.Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy[J].Retina,200g,28 (5):717-722.
  • 8Lai TY,Chan WM,Liu DT.et al.Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy[J].Br J Ophthalmol,2008,92(5):661 -666.
  • 9Ojima Y,Tsujikawa A,Otani A,et al.Recurrent bleeding after photodynamic therapy in polypoidal choroidal vasculopathy[J].Am J Ophthalmol,2006,141(5):958-960.
  • 10Otani A,Sasahara M,Yodoi Y,et al.Indocyanine green angiography:guided photodynamic therapy for polypoidal choroidal vasculopathy[J].Am J Ophthalmol,2007,144(1):7-14.

同被引文献44

  • 1戴虹,喻晓兵,卢颖毅,龙力,夏群.渗出型老年性黄斑变性重复光动力疗法的临床观察[J].中华眼底病杂志,2006,22(4):220-223. 被引量:7
  • 2文峰,吴德正,孙祖华,陈艳丽,黄时洲,罗光伟.息肉状脉络膜血管病变的分类研究[J].眼科学报,2006,22(3):160-165. 被引量:8
  • 3齐慧君,黎晓新.TTT治疗息肉状脉络膜血管病变的疗效观察[J].中国实用眼科杂志,2006,24(10):1021-1024. 被引量:6
  • 4文峰.有关息肉状脉络膜血管病变诊治的讨论[J].眼科,2007,16(6):373-375. 被引量:15
  • 5Klein R,Klein BE,Linton KL. Prevalence of age-related maculopathy the Beaver Dam Eye Study[J].OPHTHALMOLOGY,1992.933-943.
  • 6张承芬.眼底病学[M]北京:人民卫生出版社,1997331-332.
  • 7中华医学会眼科学分会眼底病学组.老年性黄斑变性临床诊断标准[J]眼底病,1987封三.
  • 8Japanese Study Group of Polypoidal Choroidal Vasculopathy. Criteria for diagnosis of polypoidal choroidal vasculopathy[J].Nihon Ganka Gakkai Zasshi,2005.417-427.
  • 9TAP Study Group. Photodynamic therapy of subfoveal choroidal neo-vasculari-zation in age-related macular degeneration with verteporfin.Two-year results of 2 randomized clinicaJ trials:TAP Report 2[J].Archives of Ophthalmology,2001.198-207.
  • 10VIP Study Group. Verteporfin therapy of subfoveal choroidal neovascu-larization in age-related macular degeneration:two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularizationv-erteporfin in photodynamic therapy report 2[J].American Journal of Ophthalmology,2001.541-560.

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部